BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36217158)

  • 1. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype.
    Katisko K; Huber N; Kokkola T; Hartikainen P; Krüger J; Heikkinen AL; Paananen V; Leinonen V; Korhonen VE; Helisalmi S; Herukka SK; Cantoni V; Gadola Y; Archetti S; Remes AM; Haapasalo A; Borroni B; Solje E
    Alzheimers Res Ther; 2022 Oct; 14(1):151. PubMed ID: 36217158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.
    Davidson YS; Barker H; Robinson AC; Thompson JC; Harris J; Troakes C; Smith B; Al-Saraj S; Shaw C; Rollinson S; Masuda-Suzukake M; Hasegawa M; Pickering-Brown S; Snowden JS; Mann DM
    Acta Neuropathol Commun; 2014 Jun; 2():70. PubMed ID: 24950788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.
    van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
    Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
    van Blitterswijk M; DeJesus-Hernandez M; Niemantsverdriet E; Murray ME; Heckman MG; Diehl NN; Brown PH; Baker MC; Finch NA; Bauer PO; Serrano G; Beach TG; Josephs KA; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Boylan KB; Petrucelli L; Dickson DW; Rademakers R
    Lancet Neurol; 2013 Oct; 12(10):978-88. PubMed ID: 24011653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy.
    Behrouzi R; Liu X; Wu D; Robinson AC; Tanaguchi-Watanabe S; Rollinson S; Shi J; Tian J; Hamdalla HH; Ealing J; Richardson A; Jones M; Pickering-Brown S; Davidson YS; Strong MJ; Hasegawa M; Snowden JS; Mann DM
    Acta Neuropathol Commun; 2016 Mar; 4():33. PubMed ID: 27036121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology.
    Nana AL; Sidhu M; Gaus SE; Hwang JL; Li L; Park Y; Kim EJ; Pasquini L; Allen IE; Rankin KP; Toller G; Kramer JH; Geschwind DH; Coppola G; Huang EJ; Grinberg LT; Miller BL; Seeley WW
    Acta Neuropathol; 2019 Jan; 137(1):27-46. PubMed ID: 30511086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.
    Suárez-Calvet M; Dols-Icardo O; Lladó A; Sánchez-Valle R; Hernández I; Amer G; Antón-Aguirre S; Alcolea D; Fortea J; Ferrer I; van der Zee J; Dillen L; Van Broeckhoven C; Molinuevo JL; Blesa R; Clarimón J; Lleó A
    J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):684-91. PubMed ID: 24309270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers.
    Mackenzie IR; Frick P; Grässer FA; Gendron TF; Petrucelli L; Cashman NR; Edbauer D; Kremmer E; Prudlo J; Troost D; Neumann M
    Acta Neuropathol; 2015 Dec; 130(6):845-61. PubMed ID: 26374446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
    Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok JB
    Neurology; 2012 Sep; 79(10):995-1001. PubMed ID: 22875086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalamic atrophy in frontotemporal dementia - Not just a
    Bocchetta M; Gordon E; Cardoso MJ; Modat M; Ourselin S; Warren JD; Rohrer JD
    Neuroimage Clin; 2018; 18():675-681. PubMed ID: 29876259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins.
    Davidson Y; Robinson AC; Liu X; Wu D; Troakes C; Rollinson S; Masuda-Suzukake M; Suzuki G; Nonaka T; Shi J; Tian J; Hamdalla H; Ealing J; Richardson A; Jones M; Pickering-Brown S; Snowden JS; Hasegawa M; Mann DM
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):242-54. PubMed ID: 26538301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study.
    Pérez-Millan A; Borrego-Écija S; van Swieten JC; Jiskoot L; Moreno F; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Tiraboschi P; Seelaar H; Langheinrich T; Rohrer JD; Sala-Llonch R; Sánchez-Valle R;
    J Neurol; 2023 Mar; 270(3):1573-1586. PubMed ID: 36443488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-incidental C9orf72 expansion mutation-related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt-Jakob disease.
    Klotz S; König T; Erdler M; Ulram A; Nguyen A; Ströbel T; Zimprich A; Stögmann E; Regelsberger G; Höftberger R; Budka H; Kovacs GG; Gelpi E
    Eur J Neurol; 2021 Mar; 28(3):1009-1015. PubMed ID: 33131137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration.
    Solomon DA; Stepto A; Au WH; Adachi Y; Diaper DC; Hall R; Rekhi A; Boudi A; Tziortzouda P; Lee YB; Smith B; Bridi JC; Spinelli G; Dearlove J; Humphrey DM; Gallo JM; Troakes C; Fanto M; Soller M; Rogelj B; Parsons RB; Shaw CE; Hortobágyi T; Hirth F
    Brain; 2018 Oct; 141(10):2908-2924. PubMed ID: 30239641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal variant of frontotemporal dementia in C9orf72 repeat expansion carriers: two case studies.
    Caso F; Agosta F; Magnani G; Cardamone R; Borghesani V; Miller Z; Riva N; La Joie R; Coppola G; Grinberg LT; Seeley WW; Miller BL; Gorno-Tempini ML; Filippi M
    Brain Imaging Behav; 2020 Apr; 14(2):336-345. PubMed ID: 32180125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.